R&D channel feed – Endpoints News

R&D channel feed

Daiichi Sankyo inks $183M discovery deal with GPCR biotech for CNS target

3 years ago

Diffusion to hand Nasdaq spot to EIP Pharma for PhIIb dementia study of ex-Vertex drug

3 years ago

Seelos Therapeutics 'temporarily' stops study in rare neuro disorder for business reasons

3 years ago

Alector cuts 11% of workforce as it doubles down on late-stage neuro programs partnered with GSK, AbbVie

3 years ago

In search of new way to deliver gene editors, CRISPR pioneer turns to molecular syringes

3 years ago

J&J bows out of RSV vaccine race, ending PhIII study and ceding to Pfizer, GSK

3 years ago

No longer ‘dead or just hibernating,’ drugmakers return to heart medicines

3 years ago

Vanda wins court case against FDA over disclosure of CRL details for sleep drug

3 years ago

Tiny multiomics biotech secures former J&J drug, new execs and new financing

3 years ago

Intra-Cellular Therapies gets a boost on PhIII depression drug data

3 years ago

Viking soars on early-stage weight loss data as it maps out PhII

3 years ago

Gunning for 2023 approval, GSK details PhIII data for Jemperli in frontline endometrial cancer

3 years ago

Applied Molecular Transport prepares to close up shop as it pauses R&D, replaces CEO, lays off 57%

3 years ago

Merck touts PhIII Keytruda data in frontline endometrial cancer

3 years ago

Gamida Cell makes more staff cuts and restructures as it focuses on potential drug launch

3 years ago

Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality

3 years ago

Who’s spending and who’s cutting from Big Pharma’s $127B R&D budget? Here are the top 15 players

3 years ago

AstraZeneca, Ionis boast full PhIII win for ATTR drug under review

3 years ago

Codiak files for Chapter 11 bankruptcy as most executives head for the exit

3 years ago

With one of biotech's largest private rounds in a year, ArriVent enters PhIII

3 years ago

Another biotech startup runs into a PhII pileup in Parkinson's

3 years ago

BrainStorm gets FDA adcomm for ALS drug after failed trial and RTF

3 years ago

Updated: FDA approves Pharming drug for ultra-rare immunodeficiency disease

3 years ago

Novo Nordisk oral semaglutide trial shows reduction in blood sugar, plus weight loss

3 years ago

First page Previous page 93 94 959697 98 99 Next page Last page